{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-018189","form_type":"8-K","ticker":"ELAB","cik":"0001840563","company_name":"PMGC Holdings Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.488208+00:00","generated_at":"2026-05-16T01:48:31.045105+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PMGC subsidiary files 10 US patent applications for EL-22/EL-32 in animal muscle growth","bullets":["NorthStrive Biosciences, wholly owned by PMGC, filed ten US patent applications expanding EL-22 and EL-32 into animal health and agriculture.","Applications cover EL-22 (5 patents) and EL-32 (5 patents) for livestock, aquaculture, and poultry including muscle growth and yield.","Two applications target livestock muscle growth: EL-22 (19/541,209) and EL-32 (19/540,888).","Additional filings address emissions reduction in livestock and aquaculture, and poultry muscle development.","This expands PMGC's IP portfolio beyond human aesthetic medicine into animal agriculture markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-018189","json":"https://secwatch.observer/filing/0001213900-26-018189.json","markdown":"https://secwatch.observer/filing/0001213900-26-018189.md","text":"https://secwatch.observer/filing/0001213900-26-018189.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026018189/0001213900-26-018189-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840563/000121390026018189/ea0277555-8k_pmgc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:48:31.045105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}